Search research articles
Contact Us
Filters
Showing results (81-90 of 217) with videos related to
Page
of 22
Sort By:
Nicotine & Tobacco Research : Official Journal of the Society for Research on Nicotine and Tobacco
|
August 30, 2008
Smoking to self-medicate attentional and emotional dysfunctions
Jean-G Gehricke, Sandra E Loughlin, Carol K Whalen, et al.
Schizophrenia Bulletin
|
November 22, 2008
A genome-wide association study of schizophrenia using brain activation as a quantitative phenotype
Steven G Potkin, Jessica A Turner, Guia Guffanti, et al.
CNS Spectrums
|
October 1, 2013
D2 receptor occupancy following lurasidone treatment in patients with schizophrenia or schizoaffective disorder
Steven G Potkin, David B Keator, Marilyn L Kesler-West, et al.
Human Psychopharmacology
|
February 16, 2016
Genetic association analysis of N-methyl-D-aspartate receptor subunit gene GRIN2B and clinical response to clozapine
Danielle L Taylor, Arun K Tiwari, Jeffrey A Lieberman, et al.
Schizophrenia Research
|
September 6, 2011
The putative functional rs1045881 marker of neurexin-1 in schizophrenia and clozapine response
Tristram A P Lett, Arun K Tiwari, Herbert Y Meltzer, et al.
Molecular Neuropsychiatry
|
March 10, 2017
Pharmacogenetic Analysis of Functional Glutamate System Gene Variants and Clinical Response to Clozapine
Danielle L Taylor, Arun K Tiwari, Jeffrey A Lieberman, et al.
Journal of Korean Medical Science
|
May 2, 2015
Functional magnetic resonance imaging of motor cortex activation in schizophrenia
Hyo Jong Lee, Adrian Preda, Judith M Ford, et al.
Journal of Alzheimer'S Disease : JAD
|
December 17, 2016
Down Syndrome, Partial Trisomy 21, and Absence of Alzheimer's Disease: The Role of APP
Eric Doran, David Keator, Elizabeth Head, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
January 6, 2005
Synthesis and evaluation of nicotine alpha4beta2 receptor radioligand, 5-(3'-18F-fluoropropyl)-3-(2-(S)-pyrrolidinylmethoxy)pyridine, in rodents and PET in nonhuman primate
Sankha Chattopadhyay, Baogang Xue, Daphne Collins, et al.
Journal of Clinical Psychopharmacology
|
June 24, 2010
A post hoc analysis of negative symptoms and psychosocial function in patients with schizophrenia: a 40-week randomized, double-blind study of ziprasidone versus haloperidol followed by a 3-year double-blind extension trial
Stephen M Stahl, Ashok Malla, John W Newcomer, et al.
Page
of 22
Search research articles
Search
Showing results (81-90 of 217) with videos related to
Sort By:
Page
of 22
Nicotine & Tobacco Research : Official Journal of the Society for Research on Nicotine and Tobacco
|
August 30, 2008
Smoking to self-medicate attentional and emotional dysfunctions
Jean-G Gehricke, Sandra E Loughlin, Carol K Whalen, et al.
Schizophrenia Bulletin
|
November 22, 2008
A genome-wide association study of schizophrenia using brain activation as a quantitative phenotype
Steven G Potkin, Jessica A Turner, Guia Guffanti, et al.
CNS Spectrums
|
October 1, 2013
D2 receptor occupancy following lurasidone treatment in patients with schizophrenia or schizoaffective disorder
Steven G Potkin, David B Keator, Marilyn L Kesler-West, et al.
Human Psychopharmacology
|
February 16, 2016
Genetic association analysis of N-methyl-D-aspartate receptor subunit gene GRIN2B and clinical response to clozapine
Danielle L Taylor, Arun K Tiwari, Jeffrey A Lieberman, et al.
Schizophrenia Research
|
September 6, 2011
The putative functional rs1045881 marker of neurexin-1 in schizophrenia and clozapine response
Tristram A P Lett, Arun K Tiwari, Herbert Y Meltzer, et al.
Molecular Neuropsychiatry
|
March 10, 2017
Pharmacogenetic Analysis of Functional Glutamate System Gene Variants and Clinical Response to Clozapine
Danielle L Taylor, Arun K Tiwari, Jeffrey A Lieberman, et al.
Journal of Korean Medical Science
|
May 2, 2015
Functional magnetic resonance imaging of motor cortex activation in schizophrenia
Hyo Jong Lee, Adrian Preda, Judith M Ford, et al.
Journal of Alzheimer'S Disease : JAD
|
December 17, 2016
Down Syndrome, Partial Trisomy 21, and Absence of Alzheimer's Disease: The Role of APP
Eric Doran, David Keator, Elizabeth Head, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
January 6, 2005
Synthesis and evaluation of nicotine alpha4beta2 receptor radioligand, 5-(3'-18F-fluoropropyl)-3-(2-(S)-pyrrolidinylmethoxy)pyridine, in rodents and PET in nonhuman primate
Sankha Chattopadhyay, Baogang Xue, Daphne Collins, et al.
Journal of Clinical Psychopharmacology
|
June 24, 2010
A post hoc analysis of negative symptoms and psychosocial function in patients with schizophrenia: a 40-week randomized, double-blind study of ziprasidone versus haloperidol followed by a 3-year double-blind extension trial
Stephen M Stahl, Ashok Malla, John W Newcomer, et al.
Page
of 22